Angola vs Cameroon: Population requiring preventive chemotherapy for schistosomiasis
Angola
5.62 million
in 2024
Cameroon
6.80 million
in 2024
Angola rank
13th
Cameroon rank
12th
Population requiring preventive chemotherapy for schistosomiasis over time
- Angola
- Cameroon
How they compare
Cameroon currently reports 6.80 million against 5.62 million in Angola, a difference of 1.18 million.
That makes Cameroon's figure about 1.2 times Angola's.
The two have swapped places 2 times across 15 shared years of data; in 2010 it was Cameroon ahead.
Angola ranks 13th and Cameroon ranks 12th of 52 countries.
Cameroon has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Angola | Cameroon | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 5.53 million | 6.46 million | 934,160 | Cameroon |
| 2020s | 5.29 million | 6.02 million | 725,354 | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Angola or Cameroon?
- Cameroon, at 6.80 million against 5.62 million in Angola as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Angola and Cameroon?
- 1.18 million, with Cameroon ahead.
- How many years of comparable data are there for Angola and Cameroon?
- 15 years are reported by both, from 2010 to 2024.
- How do Angola and Cameroon rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Angola ranks 13th and Cameroon ranks 12th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.